Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

LSC 2013 abstract - Volatile compounds of exhaled breath in lung cancer and lung inflammatory disease

Agnese Kislina, Liga Balode, Maris Bukovskis, Gunta Strazda, Normunds Jurka, Uldis Kopeika, Liene Logina, Immanuels Taivans
European Respiratory Journal 2013 42: PP133; DOI:
Agnese Kislina
2Institute of Experimental and Clinical Medicine, University of Latvia, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liga Balode
2Institute of Experimental and Clinical Medicine, University of Latvia, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maris Bukovskis
2Institute of Experimental and Clinical Medicine, University of Latvia, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gunta Strazda
1Departament of Pathology, University of Latvia, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Normunds Jurka
2Institute of Experimental and Clinical Medicine, University of Latvia, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Uldis Kopeika
1Departament of Pathology, University of Latvia, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liene Logina
2Institute of Experimental and Clinical Medicine, University of Latvia, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Immanuels Taivans
1Departament of Pathology, University of Latvia, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Challenging approach is to try to diagnose lung diseases by analysis of exhaled breath that contains volatile organic compounds (VOCs).

The aims: of this study was to compare the concentrations of VOCs in exhaled air of lung cancer patients and patients with inflammatory lung diseases and healthy controls.

Materials and methods: four study groups were formed – 31 patients - lung cancer, 19 with COPD, 11 - pneumonia and 10 healthy volunteers. Before collection of exhaled air patients lungs were washed for 5 minutes with filtered air. Exhaled breath samples were collected on termodesorbtion tubes and later analyzed on gas chromatograph / mass spectrometer.

Results: Mean concentrations of VOCs are shown in the table.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

p<0,05: * compared to healthy controls

95% CI – 95% confidence interval of mean value

Conclusions: Exhaled air of lung cancer patients contain less amounts of light spirits and hydrocarbons, compared to controls. VOCs spectrum from patients with lung inflammatory diseases doesn't differ significantly from normal controls.

  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
LSC 2013 abstract - Volatile compounds of exhaled breath in lung cancer and lung inflammatory disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
LSC 2013 abstract - Volatile compounds of exhaled breath in lung cancer and lung inflammatory disease
Agnese Kislina, Liga Balode, Maris Bukovskis, Gunta Strazda, Normunds Jurka, Uldis Kopeika, Liene Logina, Immanuels Taivans
European Respiratory Journal Sep 2013, 42 (Suppl 57) PP133;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
LSC 2013 abstract - Volatile compounds of exhaled breath in lung cancer and lung inflammatory disease
Agnese Kislina, Liga Balode, Maris Bukovskis, Gunta Strazda, Normunds Jurka, Uldis Kopeika, Liene Logina, Immanuels Taivans
European Respiratory Journal Sep 2013, 42 (Suppl 57) PP133;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial
  • LATE-BREAKING ABSTRACT: Intra-day symptoms fluctuations: STORICO, observational study on the characterization of 24-hour symptoms in COPD patients
  • LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF)
Show more 1.1 Clinical Problems

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society